Solid dispersions comprising tacrolimus

Details Solid dispersions comprising tacrolimus Solid dispersions comprising tacrolimus

2011-08-09

2011-08-09

Anderson, James (Department: 1629)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S454000, C514S338000, C514S294000, C514S885000, C424S465000, C424S468000, C424S469000

Reexamination Certificate

active

07994214

ABSTRACT:
A pharmaceutical composition comprising tacrolimus (FK-506) dissolved and/or dispersed in a hydrophilic or water-miscible vehicle to form a solid dispersion or solid solution at ambient temperature have improved bioavailability.

REFERENCES:
patent: 5601844 (1997-02-01), Kagayama et al.
patent: 6168806 (2001-01-01), Lee et al.
patent: 6204243 (2001-03-01), Posanski
patent: 6346537 (2002-02-01), Hata et al.
patent: 6387918 (2002-05-01), Yamanaka et al.
patent: 6440458 (2002-08-01), Yamashita et al.
patent: 6503883 (2003-01-01), Posanski
patent: 6576259 (2003-06-01), Yamashita et al.
patent: 6761895 (2004-07-01), Sawada et al.
patent: 6884433 (2005-04-01), Yamashita et al.
patent: 6884436 (2005-04-01), Kipp et al.
patent: 2002/0028240 (2002-03-01), Sawada et al.
patent: 2003/0180352 (2003-09-01), Patel et al.
patent: 2005/0169993 (2005-08-01), Yamashita et al.
patent: 2005/0249799 (2005-11-01), Jacob et al.
patent: 2006/0045865 (2006-03-01), Jacob et al.
patent: 2006/0159766 (2006-07-01), Jenkins et al.
patent: 2006/0177500 (2006-08-01), Shin et al.
patent: 2006/0210638 (2006-09-01), Liversidge et al.
patent: 2007/0122482 (2007-05-01), Holm et al.
patent: 0 184 162 (1986-06-01), None
patent: 0 444 659 (1991-09-01), None
patent: 1 064 942 (2001-01-01), None
patent: 1064942 (2001-01-01), None
patent: 1275373 (2003-01-01), None
patent: 1275381 (2003-01-01), None
patent: 62-277321 (1987-12-01), None
patent: 93/23022 (1993-11-01), None
patent: 98/24418 (1998-06-01), None
patent: 99/49863 (1999-10-01), None
patent: 0137808 (2001-05-01), None
patent: WO 01/37808 (2001-05-01), None
patent: 01/74359 (2001-10-01), None
patent: WO 01/95939 (2001-12-01), None
patent: WO 03/004001 (2003-01-01), None
patent: 2005/004848 (2005-01-01), None
“Tacrolimus (Systemic)”, Drugs.com, Aug. 1997, pp. 1-43 of 43, downloaded from “www.drugs.com/mmx/tacrolimus.html” on Oct. 5, 2009.
Yang et al., International Journal of Pharmaceutics, 1992, vol. 86(2-3) pp. 247-257; Abstract only, p. 1 of 1.
Kjaergaard et al., “Prilling—Multiple Core Encapsulation”, GEA Process Engineering, Inc., GEA-Niro A/S R1, Aug. 2000, downloaded from http://www.niroinc.com/food—chemical/prilling—encapsulation.asp, pp. 1-10 of 10.
Nishi et al., 2004, “The colon displays an absorptive capacity of Tacrolimus”, Transplantation Proceedings, vol. 36, No. 2, pp. 364-366.
Nishi et al., 2004, “The expression of intestinal CYP3A4 in the Piglet Model”, Transplantation Proceedings vol. 36, No. 2, pp. 361-363.
Sano et al., 2002, “Oral FK 506 blood levels . . . ” Transplantation Proceedings vol. 34, No. 3, pp. 1050-1051.
Honbo et al., 1987, “The oral dosage form of FK-506”, Transplantation Proceedings, vol. 19, No. 5 supplement 6, pp. 17-22.
Official Action for U.S. Appl. No. 10/569,862; mail date Oct. 23, 2009; 23 pages.
Office Action dated Jun. 7, 2010 in U.S. Appl. No. 10/569,862.

Affiliated with

Also associated with

Rating

Solid dispersions comprising tacrolimus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solid dispersions comprising tacrolimus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid dispersions comprising tacrolimus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2633374